Welcome to the December 2016 edition of the Competition Quarterly - an e-bulletin from the competition group at Stevens & Bolton LLP
Competition Quarterly - December 2016
Gustaf Duhs
Maliha CareyContents
- The Competition and Markets Authority's year in review: 2016
- The Competition and Markets Authority fines Pfizer and Flynn Pharma almost £90 million for charging excessive prices to the NHS
- CMA secures first disqualification of company director for breaching competition law
- Model behaviour: the Competition and Markets Authority fines modelling agencies for colluding on price
-
According to the Global Competition Review (published in July 2016), 2015 was “a slow year for behavioural enforcement” at the Competition and Markets Authority (“CMA”) and “the CMA simply needs to do more in 2016”. ... Read more
-
The Competition and Markets Authority (“CMA”) has fined pharmaceutical company Pfizer and distributor Flynn Pharma almost £90 million in total (Pfizer received a record fine of £84.2 million and Flynn Pharma was fined £5.2... Read more
-
The Competition and Markets Authority (“CMA”) has secured the first disqualification of a company director found to have infringed competition law. Under the Company Directors Disqualification Act 1986 (as amended by the Enterprise Act 2002),... Read more
-
On 16 December 2016, the CMA announced that it had fined 5 modelling agencies, FM Models, Models 1, Premier, Storm and Viva, as well as their trade association, the Association of Model Agents (“AMA”) a total of £1.5 million for infringing... Read more